• Keurig Dr Pepper recently reported second-quarter 2026 results showing sales rising to US$7.31 billion from US$4.16 billion a year earlier, while net income fell to US$142 million from US$547 million as earnings per share from continuing operations eased to US$0.04.
• A flurry of brand activity, including a lime-led reformulation of 7UP, a limited-time Dr Pepper shake collaboration at Portillo’s, and the appointment of experienced finance leader Aaron Alt to the board, highlights how Keurig Dr Pepper is focusing on product innovation and financial oversight amid changing category trends.
• We’ll now explore how Q2’s revenue surge and 7UP’s lime-forward relaunch could influence Keurig Dr Pepper’s existing investment narrative.

Find 52 companies with promising cash flow potential yet trading below their fair value.

Keurig Dr Pepper Investment Narrative Recap

To own Keurig Dr Pepper, you need to be comfortable with a business that trades near many estimates of fair value while working through margin pressure and a weaker coffee segment. The sharp Q2 2026 net income drop alongside strong revenue growth keeps profit recovery as the key short term catalyst, with sustained coffee headwinds and cost inflation remaining the most important risks. The latest announcements do not appear to materially change that near term setup.

The 7UP Lime Lemon relaunch is the announcement that most clearly connects to the current story, because it sits at the intersection of brand strength and revenue growth. By refreshing a core carbonated soft drink brand with a lime led formula and a national marketing push, Keurig Dr Pepper is leaning into one of its main potential growth drivers while coffee and input cost issues continue to weigh on overall earnings.

Yet behind the stronger soda activity, investors should also be aware of the risk that persistent coffee margin pressure and tariffs could...

Keurig Dr Pepper's narrative projects $31.8 billion revenue and $3.6 billion earnings by 2029. This requires 16.5% yearly revenue growth and a roughly $2.3 billion earnings increase from $1.3 billion today.

Uncover how Keurig Dr Pepper's forecasts yield a $35.65 fair value, a 13% upside to its current price.

Exploring Other Perspectives

Nine members of the Simply Wall St Community currently value Keurig Dr Pepper between US$22.62 and US$109.39 per share, highlighting very different expectations. As you weigh those views, keep in mind that recent margin pressure in the coffee segment and higher input costs may influence how comfortably the company can convert revenue growth into earnings over time.

Explore 9 other fair value estimates on Keurig Dr Pepper - why the stock might be worth 28% less than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Keurig Dr Pepper research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.
• Our free Keurig Dr Pepper research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Keurig Dr Pepper's overall financial health at a glance.

Want Some Alternatives?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.